Josh Hardy, who at just seven years old is a four-time cancer survivor, became well-known as his family petitioned for pharmaceutical company Chimerix to donate experimental drugs to him on compassionate grounds. The company initially refused, saying brincidofovir was too risky, but has now reneged on their earlier decision.